GB1390658A - Thiazolopyrimidine derivatives - Google Patents

Thiazolopyrimidine derivatives

Info

Publication number
GB1390658A
GB1390658A GB5205072A GB5205072A GB1390658A GB 1390658 A GB1390658 A GB 1390658A GB 5205072 A GB5205072 A GB 5205072A GB 5205072 A GB5205072 A GB 5205072A GB 1390658 A GB1390658 A GB 1390658A
Authority
GB
United Kingdom
Prior art keywords
group
general formula
thiomorpholino
reacting
hexahydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5205072A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2155963A external-priority patent/DE2155963A1/de
Priority claimed from DE19722248792 external-priority patent/DE2248792A1/de
Priority claimed from DE19722248791 external-priority patent/DE2248791A1/de
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of GB1390658A publication Critical patent/GB1390658A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50—Three nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
GB5205072A 1971-11-11 1972-11-10 Thiazolopyrimidine derivatives Expired GB1390658A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE2155963A DE2155963A1 (de) 1971-11-11 1971-11-11 Neue thiazolo eckige klammer auf 5,4-d eckige klammer zu pyrimidine
DE19722248792 DE2248792A1 (de) 1972-10-05 1972-10-05 Neue thiazolo eckige klammer auf 5,4-d eckige klammer zu pyrimidine
DE19722248791 DE2248791A1 (de) 1972-10-05 1972-10-05 Neues verfahren zur herstellung von thiazolo eckige klammer auf 5,4 - d eckige klammer zu pyrimidinen

Publications (1)

Publication Number Publication Date
GB1390658A true GB1390658A (en) 1975-04-16

Family

ID=27183827

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5205072A Expired GB1390658A (en) 1971-11-11 1972-11-10 Thiazolopyrimidine derivatives

Country Status (11)

Country Link
JP (1) JPS4885596A (en:Method)
AU (1) AU4875672A (en:Method)
BE (1) BE791242A (en:Method)
DD (1) DD105450A5 (en:Method)
FR (1) FR2159421B1 (en:Method)
GB (1) GB1390658A (en:Method)
HU (1) HU165855B (en:Method)
IL (1) IL40800A0 (en:Method)
NL (1) NL7215222A (en:Method)
PL (1) PL79689B1 (en:Method)
SU (1) SU493974A3 (en:Method)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009042607A1 (en) 2007-09-24 2009-04-02 Genentech, Inc. Thiazolopyrimidine p13k inhibitor compounds and methods of use
WO2010138589A1 (en) 2009-05-27 2010-12-02 Genentech, Inc. Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
CN103896857A (zh) * 2012-12-26 2014-07-02 上海医药工业研究院 一种4,6-二氯-2-(丙硫基)嘧啶-5-胺的制备方法
US20140315885A1 (en) * 2011-11-10 2014-10-23 Ucb Pharma S.A. Therapeutically Active Thiazolo-Pyrimidine Derivatives
US9777018B2 (en) 2011-06-09 2017-10-03 Rhizen Pharmaceuticals Sa Compounds as modulators of GPR-119

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0221828D0 (en) * 2002-09-20 2002-10-30 Astrazeneca Ab Novel compound
JP5647998B2 (ja) * 2009-03-13 2015-01-07 カトリーケ ユニバーシテイト ルーヴェン、ケー．ユー． ルーヴェン アール アンド ディー 免疫抑制剤としてのチアゾロピリミジン調節因子

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB786007A (en) * 1956-01-30 1957-11-06 Wellcome Found Thiazolo-pyrimidines

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009042607A1 (en) 2007-09-24 2009-04-02 Genentech, Inc. Thiazolopyrimidine p13k inhibitor compounds and methods of use
WO2010138589A1 (en) 2009-05-27 2010-12-02 Genentech, Inc. Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
US9777018B2 (en) 2011-06-09 2017-10-03 Rhizen Pharmaceuticals Sa Compounds as modulators of GPR-119
US20140315885A1 (en) * 2011-11-10 2014-10-23 Ucb Pharma S.A. Therapeutically Active Thiazolo-Pyrimidine Derivatives
US9096614B2 (en) * 2011-11-10 2015-08-04 Ucb Pharma S.A. Therapeutically active thiazolo-pyrimidine derivatives
CN103896857A (zh) * 2012-12-26 2014-07-02 上海医药工业研究院 一种4,6-二氯-2-(丙硫基)嘧啶-5-胺的制备方法
CN103896857B (zh) * 2012-12-26 2015-12-23 上海医药工业研究院 一种4,6-二氯-2-(丙硫基)嘧啶-5-胺的制备方法

Also Published As

Publication number Publication date
BE791242A (fr) 1973-05-10
AU4875672A (en) 1974-05-16
NL7215222A (en:Method) 1973-05-15
HU165855B (en:Method) 1974-11-28
IL40800A0 (en) 1973-01-30
JPS4885596A (en:Method) 1973-11-13
SU493974A3 (ru) 1975-11-28
PL79689B1 (en) 1975-06-30
FR2159421B1 (en:Method) 1976-03-05
DD105450A5 (en:Method) 1974-04-20
FR2159421A1 (en:Method) 1973-06-22

Similar Documents

Publication Publication Date Title
GB1449100A (en) Pyrimidine derivatives processes for their preparation and their use in pharmaceutical compositions
IE32035B1 (en) Improved process for making 1,4,5,6-tetrahydro-2-((2-substituted)vinyl)pyrimidines and 2-((2-substituted)vinyl)-2-imidazolines
GB1390658A (en) Thiazolopyrimidine derivatives
GB1287659A (en) Pyrimidinylpyrazole derivatives
GB1435573A (en) Indoloquinolizines
ES2001703A6 (es) Procedimiento para la preparracion de derrrivados de acidos 2-(2-imidazolin -2-il)- piridin -3- carboxilicos.
US3154551A (en) 4-piperazino-5-arylmercapto pyrimidines
GB1271466A (en) Thiocarbamic acid derivatives
SU517587A1 (ru) Способ получени производных 2оксфенилмочевины
ES8609269A1 (es) Procedimiento para la obtencion de derivados de 1-fluoro-1- -azolil-2,2-diaril-etano
GB1293510A (en) Thiolcarbamates
ES8601152A1 (es) Procedimiento para la obtencion de derivados de acido barbi-turico
GB1407856A (en) Anti-inflammatory thiazole compositions and methods for using same
GB1364294A (en) 2-styrylquinazoline compounds
GB1152883A (en) 4,5-Polymethylene-Pyrimidine Derivatives
GB1225462A (en:Method)
GB1449802A (en) Piperazine derivatives and compositions containing them for treating parkinsons disease
GB1345640A (en) Piperazinyl pyrimidines
GB1268469A (en) Halomethylquinolylamino-benzamides
GB1263032A (en) Process for the manufacture of tetrachloropyrimidine
GB1197692A (en) Thienylcarboxamides and their preparation
GB1355866A (en) Dibenzoxazepine derivatives
GB1285268A (en) Thiazolopyrimidines
GB1254270A (en) Benzoxazepine derivatives
IE36269L (en) SUBSTITUTED PYRIDO [3, 2-d] PYRIMIDINES

Legal Events

Date Code Title Description
CSNS Application of which complete specification have been accepted and published, but patent is not sealed